Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

CM Alvim Impl Ti 4.3X10: medical device reports filed with FDA

2,206 reports name it, 2017–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

2,206
device reports naming the brand
0% of all MAUDE reports · about 255 a year
192
reports, 12 months to August 2026
313 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,206 medical device reports received by FDA name the brand "CM Alvim Impl Ti 4.3X10" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from November 2017 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

192 reports arrived in the 12 months to August 2026, down 39% from 313 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (86.5%), loss of osseointegration (6%) and fracture (0.5%). The patient problems coded most often are pain, fibrosis and swelling/ edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0131261Sep 2021: 7Oct 2021: 5Nov 2021: 4Dec 2021: 202022Jan 2022: 2Feb 2022: 5Mar 2022: 11Apr 2022: 32May 2022: 56Jun 2022: 43Jul 2022: 32Aug 2022: 100Sep 2022: 43Oct 2022: 195Nov 2022: 64Dec 2022: 242023Jan 2023: 261Feb 2023: 37Mar 2023: 23Apr 2023: 54May 2023: 15Jun 2023: 20Jul 2023: 11Aug 2023: 37Sep 2023: 20Oct 2023: 26Nov 2023: 11Dec 2023: 32024Jan 2024: 2Feb 2024: 2Mar 2024: 2Apr 2024: 9May 2024: 17Jun 2024: 55Jul 2024: 91Aug 2024: 221Sep 2024: 97Oct 2024: 64Nov 2024: 17Dec 2024: 322025Jan 2025: 21Feb 2025: 26Mar 2025: 14Apr 2025: 1May 2025: 0Jun 2025: 38Jul 2025: 2Aug 2025: 1Sep 2025: 1Oct 2025: 37Nov 2025: 18Dec 2025: 422026Jan 2026: 25Feb 2026: 5Mar 2026: 7Apr 2026: 9May 2026: 11Jun 2026: 6Jul 2026: 26Aug 2026: 5

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03056092017: 420172018: 520182019: 1620192020: 6020202021: 9220212022: 60720222023: 51820232024: 60920242025: 20120252026: 942026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,205
Malfunction0%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report98.6%2,175
Voluntary report0%0
User facility report0%0
Distributor report1.4%31
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,90986.5%62.8%
Loss of osseointegration1326%22.4%
Fracturea broken bone120.5%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified1476.7%
Fibrosis1125.1%
Swelling/ edema622.8%
Tissue damage381.7%
Hemorrhage/blood loss/bleeding311.4%
Inflammationinflammation281.3%
Fistula180.8%
Hyperresponsive to stimuli100.5%
Abscessa collection of pus50.2%
Failure of implant40.2%
Hypersensitivity/allergic reaction40.2%
Swellingswelling30.1%
Sinus perforation20.1%
Numbnessnumbness10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCM Alvim Impl Ti 4.3X10Product code DZEAll MAUDE reports
Reports2,2063,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer98.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about CM Alvim Impl Ti 4.3X10 reports

How many FDA reports name CM Alvim Impl Ti 4.3X10?

2,206 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 192 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (86.5%), loss of osseointegration (6%) and fracture (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98.6%) and distributor reports (1.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that CM Alvim Impl Ti 4.3X10 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.